Clobetasol Attenuates White Matter Injury by Promoting Oligodendrocyte Precursor Cell Differentiation

Xuewen Su1, Haifeng Yuan1, Yuxin Bai1

  • 1Inner Mongolia People's Hospital, Hohhot, China.

Pediatric Neurosurgery
|October 11, 2020
PubMed

Insights

Clobetasol shows promise in treating white matter injury (WMI) in preterm infants. This study found clobetasol promotes oligodendrocyte precursor cell (OPC) differentiation, enhancing myelin sheath formation and improving neurobehavioral outcomes in a WMI rat model.

Area of Science:

  • Neuroscience
  • Developmental Neuroscience
  • Regenerative Medicine

Background:

  • White matter injury (WMI) is a primary cause of neurological deficits in preterm infants.
  • Damage to oligodendrocyte precursor cells (OPC) impairs myelin sheath formation, leading to long-term disability.
  • Current treatments for WMI are limited, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the potential of clobetasol as a therapeutic agent for preterm white matter injury (WMI).
  • To evaluate clobetasol's efficacy in promoting oligodendrocyte precursor cell (OPC) differentiation and myelin sheath formation.
  • To assess the impact of clobetasol on neurobehavioral functions in a rat model of WMI.

Main Methods:

  • A rat model of white matter injury (WMI) was established.
  • Rats received intraperitoneal injections of clobetasol at varying doses and treatment timings.
  • Myelin basic protein (MBP) expression, myelin sheath formation, and neurobehavioral functions were assessed.

Main Results:

  • Clobetasol treatment significantly increased myelin basic protein (MBP) expression in the WMI rat model.
  • Enhanced myelin sheath formation was observed in clobetasol-treated rats.
  • Significant improvements in neurobehavioral functions were noted in rats receiving clobetasol.

Conclusions:

  • Clobetasol effectively attenuates white matter injury (WMI) by promoting oligodendrocyte precursor cell (OPC) differentiation.
  • Clobetasol demonstrates therapeutic potential for treating white matter injury (WMI) in preterm infants.
  • Further research into clobetasol as a treatment for preterm WMI is warranted.
Abstract

Related Concept Videos

Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.4K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.8K
Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
4.8K